European Union - English - EMA (European Medicines Agency)

recordati ireland ltd - silodosin - prostatic hyperplasia - urologicals, alpha-adrenoreceptor antagonists - treatment of the signs and symptoms of benign prostatic hyperplasia (bph) in adult men.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 10mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 20mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 10mg

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 20mg

United States - English - NLM (National Library of Medicine)

recordati rare diseases, inc. - clorazepate dipotassium (unii: 63fn7g03xy) (clorazepic acid - unii:d51wo0g0l4) - clorazepate dipotassium 7.5 mg - tranxene is indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. tranxene tablets are indicated as adjunctive therapy in the management of partial seizures. the effectiveness of tranxene tablets in long-term management of anxiety, that is, more than 4 months, has not been assessed by systematic clinical studies. long-term studies in epileptic patients, however, have shown continued therapeutic activity. the physician should reassess periodically the usefulness of the drug for the individual patient. tranxene tablets are indicated for the symptomatic relief of acute alcohol withdrawal. tranxene tablets are contraindicated in patients with a known hypersensitivity to the drug and in those with acute narrow angle glaucoma.

Ireland - English - HPRA (Health Products Regulatory Authority)

recordati ireland limited - alprostadil - cream - 2 milligram(s)/gram - drugs used in erectile dysfunction; alprostadil - drugs used in erectile dysfunction - treatment of men
18 years of age with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.

Ireland - English - HPRA (Health Products Regulatory Authority)

recordati ireland limited - alprostadil - cream - 3 milligram(s)/gram - drugs used in erectile dysfunction; alprostadil - : drugs used in erectile dysfunction - treatment of men
18 years of age with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance

United States - English - NLM (National Library of Medicine)

recordati rare diseases, inc. - ethotoin (unii: 46qg38nc4u) (ethotoin - unii:46qg38nc4u) - ethotoin 250 mg - peganone (ethotoin tablets, usp) is indicated for the control of tonic-clonic (grand mal) and complex partial (psychomotor) seizures. peganone (ethotoin tablets, usp) is contraindicated in patients with hepatic abnormalities or hematologic disorders.

United States - English - NLM (National Library of Medicine)

recordati rare diseases, inc. - methamphetamine hydrochloride (unii: 997f43z9cv) (methamphetamine - unii:44ral3456c) - methamphetamine hydrochloride 5 mg - attention deficit disorder with hyperactivity: desoxyn tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or may not be warranted. in patients known to be hypersensitive to amphetamine, or other components of desoxyn. hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine p